Cite
HARVARD Citation
Koshkin, V. et al. (2022). Efficacy of enfortumab vedotin in advanced urothelial cancer: Analysis from the Urothelial Cancer Network to Investigate Therapeutic Experiences (UNITE) study. Cancer. 128 (6), pp. 1194-1205. [Online].